Stem Cell Transplant for Hematologic Diseases

NCT00058825 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

TERMINATED

Status

27

Enrollment

OTHER

Sponsor class

Stopped Slow accrual due to practice changes meant study would take too long to finish

Conditions

Hematologic Malignancies

Interventions

BIOLOGICAL: Campath 1H
DRUG: Fludarabine
PROCEDURE: Stem Cell Transplant
RADIATION: Total Body Irradiation (TBI)
DRUG: FK506 (Tacrolimus) or Cyclosporine

Sponsor

Baylor College of Medicine

Collaborators

[object Object]